Plasma cannabinoid concentrations and transference during long-term industrial hemp administration in cattle

牛长期服用工业大麻期间血浆中大麻素浓度及转移情况

阅读:2

Abstract

With recent legalization of industrial hemp (IH) production and increased interest in including IH and its byproducts in cattle feed, there is a need to establish the pharmacokinetic profiles of cannabinoids in cattle and guidelines for animal surveillance programs to ensure safety of cattle products entering the food supply. Our group has previously described the pharmacokinetics of cannabidiolic acid (CBDA) and concentrations of other cannabinoids in plasma. In the present study, the plasma cannabinoid concentrations in twelve (12) Holstein steers receiving alfalfa pellet placebo (PLBO), chlortetracycline (CTC) pellets (1.1 mg/kg/d), IH (5.5 mg/kg/d CBDA; HEMP), or a combination of CTC and IH (COMBO) once daily for 63 d were evaluated. Plasma samples were collected every 7 d from day -7 to 77. Eleven cannabinoids were detected above the lower limit of quantification (LLOQ), with the cannabinoid (-)-7-nor-7-carboxy cannabidiol (CBD-7-acid) reaching the highest concentrations. All cannabinoids except CBD-7-acid were below LLOQ by 14 d after final hemp administration. In cattle not receiving IH, CBD-7-acid was detected in multiple steers and timepoints. CBDA was detected in 4 samples (2 steers from each of the PLBO and CTC groups). Both 9-THC and its precursor, THCA, were detected above LLOQ in a singular sample from a steer in the CTC group. These findings suggest that cattle not receiving IH could have detectable concentrations of CBD-7-acid in the blood if cohoused with animals that are exposed to IH. Sample contamination may have been responsible for the detectable 9-THC, THCA, and CBDA concentrations. Based on our results, CBD-7-acid may be a useful tool for screening cattle for IH exposure. However, given the consistent, detectable concentrations in groups not administered IH, a confirmatory test or specific criteria for interpreting CBD-7-acid concentrations would be warranted. These data will help inform decisions regarding surveillance and tolerances for cannabinoid testing in food animals and animal products entering the food supply.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。